Q32 Bio (QTTB) FCF Margin (QoQ) (2018 - 2023)

Q32 Bio (QTTB) FCF Margin (QoQ) (2018 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Q32 Bio 215.66 Mn 164.91 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -6,743.00
Sep 30, 2023 121,081.00
Jun 30, 2023 6,774.00
Mar 31, 2023 296,927.00
Dec 31, 2022 -28,304.00
Sep 30, 2022 88,766.00
Jun 30, 2022 -16,384.00
Mar 31, 2022 25,549.00
Dec 31, 2021 -266,719.00
Sep 30, 2021 -26,361.00
Jun 30, 2021 -105,496.00
Mar 31, 2021 102,402.00
Dec 31, 2020 408,178.00
Sep 30, 2020 -62,610.00
Jun 30, 2020 15,861.00
Mar 31, 2020 369,278.00
Dec 31, 2019 -621,619.00
Sep 30, 2019 614,459.00
Jun 30, 2019 20,972.00
Mar 31, 2019 -660,341.00